BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 25627399)

  • 1. Practical approach to the use of daylight photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: a European consensus.
    Morton CA; Wulf HC; Szeimies RM; Gilaberte Y; Basset-Seguin N; Sotiriou E; Piaserico S; Hunger RE; Baharlou S; Sidoroff A; Braathen LR
    J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1718-23. PubMed ID: 25627399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daylight photodynamic therapy with MAL cream for large-scale photodamaged skin based on the concept of 'actinic field damage': recommendations of an international expert group.
    Philipp-Dormston WG; Sanclemente G; Torezan L; Tretti Clementoni M; Le Pillouer-Prost A; Cartier H; Szeimies RM; Bjerring P
    J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):8-15. PubMed ID: 26552049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia.
    See JA; Shumack S; Murrell DF; Rubel DM; Fernández-Peñas P; Salmon R; Hewitt D; Foley P; Spelman L
    Australas J Dermatol; 2016 Aug; 57(3):167-74. PubMed ID: 26033230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spanish-Portuguese consensus statement on use of daylight-mediated photodynamic therapy with methyl aminolevulinate in the treatment of actinic keratosis.
    Gilaberte Y; Aguilar M; Almagro M; Correia O; Guillén C; Harto A; Pérez-García B; Pérez-Pérez L; Redondo P; Sánchez-Carpintero I; Serra-Guillén C; Valladares LM
    Actas Dermosifiliogr; 2015 Oct; 106(8):623-31. PubMed ID: 26115793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
    Rubel DM; Spelman L; Murrell DF; See JA; Hewitt D; Foley P; Bosc C; Kerob D; Kerrouche N; Wulf HC; Shumack S
    Br J Dermatol; 2014 Nov; 171(5):1164-71. PubMed ID: 24861492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe.
    Lacour JP; Ulrich C; Gilaberte Y; Von Felbert V; Basset-Seguin N; Dreno B; Girard C; Redondo P; Serra-Guillen C; Synnerstad I; Tarstedt M; Tsianakas A; Venema AW; Kelleners-Smeets N; Adamski H; Perez-Garcia B; Gerritsen MJ; Leclerc S; Kerrouche N; Szeimies RM
    J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2342-8. PubMed ID: 26435363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daylight Photodynamic Therapy for Actinic Keratoses.
    Morton CA; Braathen LR
    Am J Clin Dermatol; 2018 Oct; 19(5):647-656. PubMed ID: 29752702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daylight-mediated photodynamic therapy for actinic damage in Latin America: consensus recommendations.
    Grinblat B; Galimberti G; Chouela E; Sanclemente G; Lopez M; Alcala D; Torezan L; Pantoja G
    Photodermatol Photoimmunol Photomed; 2016 Mar; 32(2):81-7. PubMed ID: 26541910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate.
    Neittaanmäki-Perttu N; Karppinen TT; Grönroos M; Tani TT; Snellman E
    Br J Dermatol; 2014 Nov; 171(5):1172-80. PubMed ID: 25109244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single versus two-treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient randomized trial.
    Gutiérrez García-Rodrigo C; Pellegrini C; Piccioni A; Tambone S; Fargnoli MC
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():100-104. PubMed ID: 31141730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial.
    Wiegell SR; Haedersdal M; Eriksen P; Wulf HC
    Br J Dermatol; 2009 Jun; 160(6):1308-14. PubMed ID: 19416257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study.
    Wiegell SR; Fabricius S; Gniadecka M; Stender IM; Berne B; Kroon S; Andersen BL; Mørk C; Sandberg C; Ibler KS; Jemec GB; Brocks KM; Philipsen PA; Heydenreich J; Hædersdal M; Wulf HC
    Br J Dermatol; 2012 Jun; 166(6):1327-32. PubMed ID: 22250644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A consensus on the use of daylight photodynamic therapy in the UK.
    Ibbotson S; Stones R; Bowling J; Campbell S; Kownacki S; Sivaramakrishnan M; Valentine R; Morton CA
    J Dermatolog Treat; 2017 Jun; 28(4):360-367. PubMed ID: 27788605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.
    Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1926-32. PubMed ID: 25809617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Procedure for daylight methyl aminolevulinate photodynamic therapy to treat actinic keratoses].
    Girard C; Adamski H; Basset-Séguin N; Beaulieu P; Dreno B; Riboulet JL; Lacour JP
    Ann Dermatol Venereol; 2016 Apr; 143(4):257-63. PubMed ID: 27016200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient and physician satisfaction in an observational study with methyl aminolevulinate daylight photodynamic therapy in the treatment of multiple actinic keratoses of the face and scalp in six European countries.
    Fargnoli MC; Ibbotson SH; Hunger RE; Rostain G; Gaastra MTW; Eibenschutz L; Cantisani C; Venema AW; Medina S; Kerrouche N; Pérez-Garcia B
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):757-762. PubMed ID: 29136306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on photodynamic treatment for actinic keratosis.
    Wiegell SR
    Curr Probl Dermatol; 2015; 46():122-8. PubMed ID: 25561216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daylight PDT with MAL - current data and practical recommendations of an expert panel.
    Philipp-Dormston WG; Karrer S; Petering H; Ulrich C; Dirschka T; Berking C; Lonsdorf AS; Gerber PA; Radakovic S; Hunger RE; Szeimies RM
    J Dtsch Dermatol Ges; 2015 Dec; 13(12):1240-9. PubMed ID: 26612792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bucher's indirect comparison of daylight photodynamic therapy with methyl aminolevulinate cream versus diclofenac plus hyaluronic acid gel for the treatment of multiple actinic keratosis.
    Calzavara-Pinton P; Zane C; Pacou M; Szeimies RM
    Eur J Dermatol; 2016 Oct; 26(5):487-492. PubMed ID: 27352420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
    Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
    Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.